Clinical Trial Update: Cadonilimab Combined With Anlotinib Followed by Radiotherapy in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (CAR-RMEC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Cadonilimab in combination with Anlotinib, followed by radiotherapy, for recurrent or metastatic esophageal squamous cell ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Anlotinib (anlotinib)
• Cadonilimab

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Esophageal Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING